Enzon Pharmaceuticals Inc
OTC:ENZN
Enzon Pharmaceuticals Inc
OTC:ENZN
Price:
6
USD
8.11%
Market Closed
Market Cap:
$4.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Great Quest Fertilizer Ltd
OTC:GQMLF
|
CA |
|
Panda Dairy Corp
SZSE:300898
|
CN |
|
I
|
InfoVision Optoelectronics Kunshan Co Ltd
SSE:688055
|
CN |
|
S
|
Super Group Ltd
XBER:S8G1
|
ZA |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
C
|
Caida Securities Co Ltd
SSE:600906
|
CN |
|
TVS Holdings Ltd
NSE:TVSHLTD
|
IN |
|
China Everbright Greentech Ltd
HKEX:1257
|
HK |
|
Gannett Co Inc
NYSE:GCI
|
US |
|
C
|
China Yuhua Education Corp Ltd
HKEX:6169
|
CN |
|
Beijing Global Safety Technology Co Ltd
SZSE:300523
|
CN |
|
Societe Industrielle et Financiere de l'Artois SA
PAR:ARTO
|
FR |
|
Genetic Signatures Ltd
ASX:GSS
|
AU |
|
Irisity AB (publ)
F:69M
|
SE |
|
Plus500 Ltd
LSE:PLUS
|
IL |
|
C
|
Cloudwalk Technology Co Ltd
SSE:688327
|
CN |
|
P
|
Peakstone Realty Trust
NYSE:PKST
|
US |
|
Idacorp Inc
NYSE:IDA
|
US |
|
M
|
Metsera Inc
NASDAQ:MTSR
|
US |
|
HealthStream Inc
NASDAQ:HSTM
|
US |
|
Fangzhou Inc
HKEX:6086
|
CN |
|
D
|
Despec Bilgisayar Pazarlama ve Ticaret AS
IST:DESPC.E
|
TR |
|
A
|
Adaro Energy Indonesia TBK PT
F:A64
|
ID |
Multiples-Based Value
The Multiples-Based Value of one
ENZN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 6 USD,
Enzon Pharmaceuticals Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ENZN Multiples-Based Value
LOCKED
Multiples Across Competitors
ENZN Competitors Multiples
Enzon Pharmaceuticals Inc Competitors
Enzon Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
4.5m USD | 0 | -80.5 | 7.2 | 7.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.5B USD | 6.1 | 89.7 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.7B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176.3B USD | 6 | 20.7 | 12.9 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.5B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.2B USD | 5.7 | 18 | 13.5 | 15.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 11.8 | 37.9 | 40.9 | 41.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 32.8 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
